Shay Shemesh

Companies

• Nuvectis Pharma, Inc.Chief Development Officer Feb 8, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NPNuvectis Pharma, Inc. NVCT1,793,068 shares²$33.9M at $18.93Jan 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 6, 2026Granted 150,000 shares of Nuvectis Pharma, Inc.²
• Jan 2, 2025Granted 150,000 shares of Nuvectis Pharma, Inc.³
• May 10, 2024Bought 1,113 shares at $6.32 of Nuvectis Pharma, Inc.⁴
• Jan 3, 2024Granted 130,000 shares of Nuvectis Pharma, Inc.⁵
• Mar 21, 2023Bought 420 shares at $11.99 of Nuvectis Pharma, Inc.⁶
• Mar 15, 2023Bought 670 shares at $10.71 of Nuvectis Pharma, Inc.⁷
• Jan 12, 2023Granted 115,000 shares of Nuvectis Pharma, Inc.⁸
• Dec 21, 2022Bought 500 shares at $7.65 of Nuvectis Pharma, Inc.⁹
• Nov 17, 2022Bought 150 shares at $7.20 of Nuvectis Pharma, Inc.¹⁰
• Nov 16, 2022Bought 150 shares at $7.10 of Nuvectis Pharma, Inc.¹⁰
• Sep 23, 2022Bought 220 shares at $7.87 of Nuvectis Pharma, Inc.¹¹
• Sep 2, 2022Bought 404 shares at $8.31 of Nuvectis Pharma, Inc.¹²
• Sep 1, 2022Bought 1,530 shares at $8.07 of Nuvectis Pharma, Inc.¹³
• Aug 31, 2022Bought 1,476 shares at $8.07 of Nuvectis Pharma, Inc.¹³
• May 20, 2022Bought 300 shares at $16.54 of Nuvectis Pharma, Inc.¹⁴
• May 17, 2022Bought 142 shares at $19.55 of Nuvectis Pharma, Inc.¹⁵
• May 16, 2022Bought 100 shares at $19.28 of Nuvectis Pharma, Inc.¹⁵
• May 12, 2022Bought 58 shares at $16.61 of Nuvectis Pharma, Inc.¹⁶
• May 12, 2022Bought 1,184 shares at $15.85 of Nuvectis Pharma, Inc.¹⁶
• May 12, 2022Bought 36 shares at $14.58 of Nuvectis Pharma, Inc.¹⁶
• Apr 1, 2022Granted 60,000 shares of Nuvectis Pharma, Inc.¹⁷
• Feb 7, 2022Bought 846 shares at $3.47 of Nuvectis Pharma, Inc.¹⁸
• Feb 4, 2022Bought 2,100 shares at $3.38 of Nuvectis Pharma, Inc.¹⁸